DIM
TWST icon

DC Investments Management’s Twist Bioscience TWST Stock Holding History

DC Investments Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-42,858
Closed -$990K – 269
2018
Q4 		$990K Buy
+42,858
New +$950K 0.81% 9

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

DC Investments Management's TWST Position: Q1 2019 in Review

DC Investments Management sold out of Twist Bioscience (TWST) in Q1 2019, closing a stake of 42,858 shares — an estimated $990K sold.

DC Investments Management first reported a position in TWST in Q4 2018 and held it in 1 quarter. The position peaked at $990K in Q4 2018. 49 funds tracked by Wall St. Rank hold TWST as of Q1 2019.

  • DC Investments Management reported no remaining Twist Bioscience position as of Q1 2019 after selling out during the quarter.
  • DC Investments Management sold 42,858 Twist Bioscience shares in Q1 2019, an estimated $990K.
  • DC Investments Management first reported a position in Twist Bioscience in Q4 2018 and held it in 1 quarter.
  • DC Investments Management's Twist Bioscience position peaked at $990K in Q4 2018.
  • 49 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2019.

Based on DC Investments Management's 13F filing for Q1 2019, filed 6 May 2019.